Clinical Impact of a Rapid Genetic Testing Model for Advanced Prostate Cancer Patients.

ABSTRACT:

Purpose

Genetic testing may alter clinical management for individuals with metastatic prostate cancer by identifying additional therapies. Traditional counseling models are unlikely to enable time-sensitive therapeutic decision-making. This study aimed to determine the feasibility and clinical impact of an alternative hereditary genetic testing model.

Materials and methods

As part of a multicenter, single-arm prospective trial, individuals with advanced prostate cancer were referred by their oncologist for testing of 14 genes associated with hereditary prostate cancer. Pretest education (brochure and video) was provided in the oncology clinic. Questionnaires assessing participant satisfaction with both pretest education and decision to undergo genetic testing were collected.

SUBMITTER: Breen KE 

PROVIDER: S-EPMC10081955 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature